, Tracking Stock Market Picks
Enter Symbol:
Catamaran Corp (CTRX) [hlAlert]

up 178.33 %

SXC Health Solutions Corp. (SXCI) rated Buy with price target $84 by Maxim Group

Posted on: Friday,  Feb 24, 2012  10:25 AM ET by Maxim Group

Maxim Group rated Buy Catamaran Corp (NASDAQ: CTRX) on 02/24/2012. Previously Maxim Group rated Buy Catamaran Corp (NASDAQ: CTRX) on 01/07/2011.,
when the stock price was $22.09. Since then, Catamaran Corp has gained 178.33% as of 07/23/2015's recent price of $61.47.
If you would have followed the previous Maxim Group's recommendation on CTRX, you would have gained 178.33% of your investment in 1658 days.

SXC Health Solutions Corp. is a provider of pharmacy benefit management (PBM) services and healthcare IT (HCIT) solutions to the healthcare benefit management industry. The Company?s product offerings and solutions combine a range of PBM software applications, application service provider (ASP) processing and pharmacy benefit management services, and professional services designed for the organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, retail pharmacy chains, and state and federal government entities. The Company?s PBM services include electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail service pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, preferred drug management programs, drug review and analysis, consulting services, data access, and reporting and information analysis.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/24/2012 10:25 AM Buy
34.74 42.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/21/2011 9:25 AM Buy
28.85 35.50
10/24/2011 3:25 PM Buy
22.26 29.50
1/7/2011 9:25 AM Buy
22.09 27.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy